Butibufen
Based on 1 Customer Validation
Butibufen is an orally active non-steroidal compound. Butibufen shows analgesic and antipyretic properties. Butibufen can be used for the research of inflammation.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 98.91%
- CAS No.: 55837-18-8
- Formule: C14H20O2
- Masse moléculaire:220.31
-
Stockage:Pure form -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
-
Orally Active Compound Library
HY-L061
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Bioactive Compound Library
HY-L001
-
High-Throughput Bioactive Compound Library
HY-L205
-
Immunology/Inflammation Compound Library
HY-L007
-
Membrane Transporter/Ion Channel Compound Library
HY-L011
-
Metabolism/Protease Compound Library
HY-L012
Activité biologique
Butibufen (0.1 μM-0.1 M; 60 min) affects cell viability and cell attachment with a high dose[2]. Butibufen (1 μM; 48 h) causes a 100% cell death after 48 h exposure[2]. Butibufen (2 μM-1 mM; 6 h) affects synthesis of albumin in hepatocytes[2]. Butibufen (0.2-0.4 mM; 6 h) impaires gluconeogenesis from lactate and significantly inhibited ureogenesis[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Hepatocytes from Sprague-Dawley male rats
-
Concentration:0.1 μM-0.1 M
-
Incubation Time:60 min
-
Result:Showed no cell viability effects under the dose of 200 μM, but dose- and time-dependently affected cell viability with higher concentrations.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague-Dawley rats[3]
-
Dosage:50 and 250 mg/kg
-
Administration:Oral gavage; 50 and 250 mg/kg; 8 and 3 h before sacrifice
-
Result:Reduced acid phosphatase activity but showed no effect on the stabilization of lysosomal membrane.
Chemical Information
-
CAS No. 55837-18-8
-
Appearance Solid-Liquid Mixture
-
Masse moléculaire 220.31
-
Formule C14H20O2
-
SMILES
CCC(C(O)=O)C1=CC=C(C=C1)CC(C)C
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Pure form -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Pureté et documentation
Références
[1]. Aparicio L. Some aspects of the pharmacology of butibufen, a non-steroidal anti-inflammatory agent. Arch Int Pharmacodyn Ther. 1977 May;227(1):130-41. [Content Brief]
[2]. Castell JV, et al. A study of the relative hepatotoxicity in vitro of the non-steroidal anti-inflammatory drugs ibuprofen, flurbiprofen and butibufen. Xenobiotica. 1988 Jun;18(6):737-45. [Content Brief]
[3]. Alamo C, et al. Influence of butibufen on enzyme activity and lysosomal stabilization ex vivo: a comparative study with hydrocortisone and acetylsalicylic acid. Methods Find Exp Clin Pharmacol. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Butibufen Related Classifications
HY-121132 Related Classifications
Powered by Bioz